Edition:
United States

Rosetta Genomics Ltd (ROSG.OQ)

ROSG.OQ on NASDAQ Stock Exchange Capital Market

1.09USD
22 Jul 2016
Change (% chg)

$0.01 (+0.93%)
Prev Close
$1.08
Open
$1.12
Day's High
$1.12
Day's Low
$1.09
Volume
6,232
Avg. Vol
30,712
52-wk High
$3.30
52-wk Low
$0.71

ROSG.OQ

Chart for ROSG.OQ

About

Rosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next... (more)

Overall

Beta: -3.53
Market Cap(Mil.): $22.73
Shares Outstanding(Mil.): 20.86
Dividend: --
Yield (%): --

Financials

  ROSG.OQ Industry Sector
P/E (TTM): -- 41.38 36.72
EPS (TTM): -- -- --
ROI: -- -5.08 14.32
ROE: -- -3.41 15.54

BRIEF-Rosetta Genomics Ltd announces agreement with Preferred Provider Organization

* Rosetta expands managed care coverage with new preferred provider agreement for entire suite of diagnostic tests and services Source text for Eikon: Further company coverage:

Jun 23 2016

BRIEF-Rosetta Genomics announces receipt of conditional approval

* Receipt of conditional approval from new york state department of health for company's allele-specific pcr based assays Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

May 23 2016

BRIEF-Rosetta Genomics Q1 non-gaap loss per share $0.18 excluding items

* Company's current operations and plans include a cost-reduction plan should it be unable to raise sufficient additional capital

May 19 2016

BRIEF-Rosetta Genomics files for mixed shelf of up to $75 mln

* Files for mixed shelf of up to $75 million - sec filing Source text: Further company coverage: (Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223 8780)

Mar 23 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.